Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02638103 |
|---|---|
| Brief Title: | Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine (HALO) |
| First Submitted : | December 18, 2015 |
| First Submitted that Met QC Criteria : | December 18, 2015 |
| First Posted : | December 22, 2015 (Estimate) |
| Results First Submitted : | June 5, 2019 |
| Results First Submitted that Met QC Criteria : | August 12, 2019 |
| Results First Posted : | August 28, 2019 |
| Last Update Submitted that Met QC Criteria : | February 17, 2020 |
| Last Update Posted : | February 28, 2020 |